Concepedia

Ryohei Katayama

RK

Statistics

Publications

73

Citations

13.5K

H-Index

41

Active since

2002

Affiliations

Japanese Foundation For Cancer Research(Current)

The University of Tokyo

Massachusetts General Hospital

Kyoto University

The Cancer Institute Hospital

Ryohei Katayama is an author at Japanese Foundation For Cancer Research specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2002–2025

73

Publications

73

<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers

Kristin Bergethon, Alice T. Shaw, Sai‐Hong Ignatius Ou et al. · Journal of Clinical Oncology · 2012 · 1.6K citations · Full text

, , +16

Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers

Ryohei Katayama, Alice T. Shaw, Tahsin Khan et al. · Science Translational Medicine · 2012 · 1.3K citations

, , +17

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in <i>ALK</i> -Rearranged Lung Cancer

Justin F. Gainor, Leila Dardaei, Satoshi Yoda et al. · Cancer Discovery · 2016 · 1.1K citations · Full text

, , +10

The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer

Luc Friboulet, Nanxin Li, Ryohei Katayama et al. · Cancer Discovery · 2014 · 842 citations · Full text

, , +15

Patient-derived models of acquired resistance can identify effective drug combinations for cancer

Adam Crystal, Alice T. Shaw, Lecia V. Sequist et al. · Science · 2014 · 733 citations

, , +17

1–5 of 73